Advertisement
LYRA 外汇新闻
Lyra Therapeutics Reports Positive Topline Results From BEACON Phase 2 Study Of LYR-220
Biotechnology company Lyra Therapeutics, Inc. (LYRA) announced Tuesday positive topline results from the BEACON Phase 2 clinical study of LYR-220 in adult patients with CRS, with and without polyps, who have had prior ethmoid sinus surgery.
RTTNews
|
697天前
